Medical Cannabis
Cannabis is a complex plant, and the impact of cannabis is growing exponentially as several potential treatment areas are covered, including research working to reveal more medical and pharmaceutical benefits, as well as a range of worldwide applications investigating the effects of cannabis.
The cannabis plant contains over 100 active substances called: Cannabinoids.
Cannabinoids
Cannabinoids are active chemical compounds found in the cannabis plat or synthetic produced compounds that can interact with the human endocannabinoid system.
Cannabinoids are active chemicals that affect receptors in the brain and human body when consumed. The two most known are Tetrahydrocannabinol (THC) and Cannabidiol (CBD).
Cannabinoids consist in three different types: those the body itself makes (Endocannabinoids), those that come from plants
(Phytocannabinoids) and those that are synthesized artificially (i.e from gene modified yeast). Cannabinoids are involved in appetite, blood pressure, blood flow to the brain, digestion, nausea, immune system, inflammation, memory, mood, movement, pain, energy balance, reproduction and stress.
The discovery of the endocannabionids led researchers to the discovery of a novel physiological system, a key component of human health and self-healing ability: The Endocannabinoid System.
Pharmaceutical cannabis means the term for formulated, processed or synthetic cannabis sold as a finished product, which has undergone full medical trials, and holds (in one or more geographical areas) a medical marketing authorization e.g., Cesamet®, Marinol®, Syndros®, Sativex®, Epidiolex® and any derived generic medicines (such as dronabinol).
Medical cannabis means the term for cannabinoid-based medicine not holding marketing authorization and therefore, sold as an unlicensed medicine that is supplied through health systems and prescribed by a doctor; or Active Pharmaceutical Ingredient (API) to be manipulated and/or compounded by a magistral pharmacy in order to prepare a cannabinoid-based medicine without marketing authorization (unlicensed).
DanCann Pharma’s own manufactured bulk product produced in our Danish facility in Ansager, that we from 2023 will export in dried form to European markets.
Latest Press Releases
Below you can learn more about DanCann and our work with medicinal cannabis.
